LPL Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.84M | Buy |
36,155
+10,575
| +41% | +$1.85M | ﹤0.01% | 2355 |
|
|
2025
Q4 | $4.35M | Buy |
25,580
+992
| +4% | +$152K | ﹤0.01% | 2655 |
|
|
2025
Q3 | $3.24M | Buy |
24,588
+85
| +0.3% | +$10.2K | ﹤0.01% | 2867 |
|
|
2025
Q2 | $2.6M | Sell |
24,503
-1,266
| -5% | -$138K | ﹤0.01% | 2878 |
|
|
2025
Q1 | $3.2M | Buy |
25,769
+3,264
| +15% | +$426K | ﹤0.01% | 2516 |
|
|
2024
Q4 | $2.77M | Buy |
22,505
+553
| +3% | +$65.2K | ﹤0.01% | 2559 |
|
|
2024
Q3 | $2.45M | Buy |
21,952
+8,809
| +67% | +$965K | ﹤0.01% | 2540 |
|
|
2024
Q2 | $1.4M | Sell |
13,143
-2,890
| -18% | -$318K | ﹤0.01% | 2932 |
|
|
2024
Q1 | $1.93M | Buy |
16,033
+1,651
| +11% | +$202K | ﹤0.01% | 2562 |
|
|
2023
Q4 | $1.77M | Buy |
14,382
+1,275
| +10% | +$159K | ﹤0.01% | 2518 |
|
|
2023
Q3 | $1.7M | Buy |
13,107
+3,707
| +39% | +$494K | ﹤0.01% | 2438 |
|
|
2023
Q2 | $1.17M | Buy |
9,400
+1,268
| +16% | +$171K | ﹤0.01% | 2722 |
|
|
2023
Q1 | $1.19M | Sell |
8,132
-1,774
| -18% | -$262K | ﹤0.01% | 2610 |
|
|
2022
Q4 | $1.58M | Buy |
9,906
+1,198
| +14% | +$176K | ﹤0.01% | 2268 |
|
|
2022
Q3 | $1.16M | Buy |
8,708
+548
| +7% | +$83.3K | ﹤0.01% | 2421 |
|
|
2022
Q2 | $1.27M | Buy |
8,160
+1,415
| +21% | +$218K | ﹤0.01% | 2379 |
|
|
2022
Q1 | $1.05M | Sell |
6,745
-646
| -9% | -$93.7K | ﹤0.01% | 2573 |
|
|
2021
Q4 | $942K | Sell |
7,391
-1,173
| -14% | -$154K | ﹤0.01% | 2710 |
|
|
2021
Q3 | $1.11M | Sell |
8,564
-4,709
| -35% | -$711K | ﹤0.01% | 2524 |
|
|
2021
Q2 | $2.36M | Buy |
13,273
+6,064
| +84% | +$1.05M | ﹤0.01% | 1840 |
|
|
2021
Q1 | $1.19M | Buy |
7,209
+128
| +2% | +$21.1K | ﹤0.01% | 2245 |
|
|
2020
Q4 | $1.17M | Sell |
7,081
-1,893
| -21% | -$282K | ﹤0.01% | 2062 |
|
|
2020
Q3 | $1.28M | Sell |
8,974
-245
| -3% | -$30.4K | ﹤0.01% | 1739 |
|
|
2020
Q2 | $1.02M | Buy |
9,219
+868
| +10% | +$96K | ﹤0.01% | 1810 |
|
|
2020
Q1 | $833K | Sell |
8,351
-947
| -10% | -$122K | ﹤0.01% | 1744 |
|
|
2019
Q4 | $1.39M | Buy |
9,298
+1,216
| +15% | +$165K | ﹤0.01% | 1618 |
|
|
2019
Q3 | $1.04M | Sell |
8,082
-542
| -6% | -$72.7K | ﹤0.01% | 1708 |
|
|
2019
Q2 | $1.23M | Sell |
8,624
-158
| -2% | -$21.2K | ﹤0.01% | 1589 |
|
|
2019
Q1 | $1.25M | Sell |
8,782
-52
| -0.6% | -$6.78K | ﹤0.01% | 1499 |
|
|
2018
Q4 | $1.09M | Buy |
8,834
+285
| +3% | +$42.3K | ﹤0.01% | 1459 |
|
|
2018
Q3 | $1.44M | Sell |
8,549
-9,253
| -52% | -$1.59M | ﹤0.01% | 1398 |
|
|
2018
Q2 | $3.07M | Buy |
17,802
+13,001
| +271% | +$2.13M | 0.01% | 922 |
|
|
2018
Q1 | $725K | Buy |
4,801
+1,041
| +28% | +$153K | ﹤0.01% | 1842 |
|
|
2017
Q4 | $506K | Buy |
3,760
+151
| +4% | +$20.9K | ﹤0.01% | 2064 |
|
|
2017
Q3 | $528K | Buy |
3,609
+436
| +14% | +$65.9K | ﹤0.01% | 1907 |
|
|
2017
Q2 | $493K | Sell |
3,173
-57
| -2% | -$8.72K | ﹤0.01% | 1891 |
|
|
2017
Q1 | $464K | Sell |
3,230
-471
| -13% | -$61.3K | ﹤0.01% | 1872 |
|
|
2016
Q4 | $411K | Buy |
+3,701
| New | +$412K | ﹤0.01% | 1905 |
|
|
2016
Q2 | – | Sell |
-11,545
| Closed | -$1.54M | – | 2805 |
|
|
2016
Q1 | $1.54M | Sell |
11,545
-302
| -3% | -$37.6K | ﹤0.01% | 1358 |
|
|
2015
Q4 | $1.63M | Buy |
11,847
+5,746
| +94% | +$796K | ﹤0.01% | 1309 |
|
|
2015
Q3 | $810K | Sell |
6,101
-12,250
| -67% | -$2.11M | ﹤0.01% | 1405 |
|
|
2015
Q2 | $3.27M | Buy |
18,351
+3,203
| +21% | +$575K | 0.02% | 688 |
|
|
2015
Q1 | $2.59M | Sell |
15,148
-1,814
| -11% | -$311K | 0.01% | 789 |
|
|
2014
Q4 | $2.78M | Sell |
16,962
-961
| -5% | -$160K | 0.02% | 730 |
|
|
2014
Q3 | $2.78M | Buy |
17,923
+1,531
| +9% | +$235K | 0.02% | 702 |
|
|
2014
Q2 | $2.41M | Sell |
16,392
-1,657
| -9% | -$230K | 0.01% | 785 |
|
|
2014
Q1 | $2.5M | Buy |
18,049
+3,158
| +21% | +$475K | 0.02% | 725 |
|
|
2013
Q4 | $1.89M | Buy |
14,891
+8,449
| +131% | +$874K | 0.01% | 853 |
|
|
2013
Q3 | $542K | Buy |
6,442
+1,627
| +34% | +$131K | ﹤0.01% | 1589 |
|
|
2013
Q2 | $331K | Buy |
+4,815
| New | +$294K | ﹤0.01% | 1838 |
|
Other funds holding JAZZ
VPM
VCM
EC
LPL Financial's JAZZ Position: Q1 2026 in Review
LPL Financial increased its Jazz Pharmaceuticals (JAZZ) stake by 41% in Q1 2026, buying an estimated $1.85M and bringing the position to 36,155 shares worth $6.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2355.
LPL Financial first reported a position in JAZZ in Q2 2013 and has held it in 50 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- LPL Financial held 36,155 shares of Jazz Pharmaceuticals worth $6.84M as of Q1 2026.
- LPL Financial bought 10,575 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.85M.
- Jazz Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #2355 holding.
- LPL Financial first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.